Recent Headlines
Ohio Motorcyclists Raise Funds for the PBTF
Motorcyclists from the Buckeye State banded together for children fighting brain tumors at the 24th Marysville Ride for Kids over the weekend. The July 11 event, which benefited the Pediatric Brain Tumor Foundation, honored local brain tumor survivors Erin, Jared, Naomi and Seth as Ride for Kids... - July 15, 2015 - Pediatric Brain Tumor Foundation
ValueCentric Announces Advanced Service Level Monitoring Module
The module is part of a series of solution-oriented modules designed to provide users with one-click solutions to common problems. - July 15, 2015 - ValueCentric
A Fully Functional Diagnostic Laboratory in a Box - MoBiTec GmbH, Germany, Offers Coyote Bioscience's MD-Box-Lab
Whether a veterinarian in the field or a tropical disease specialist in the savanna - one of the things they certainly do miss most is a fully operational laboratory for reliable molecular biologically supported diagnostics. - July 15, 2015 - MoBiTec GmbH
Northern Indiana Motorcyclists Unite for Kids
Motorcyclists showed their support for children with brain tumors by raising $53,920 for the Pediatric Brain Tumor Foundation on June 28. More than 200 participants gathered for the Northern Indiana Ride for Kids in South Bend to honor brain tumor survivors Adler, Daniel, Hannah, Jayden, Jennifer... - July 01, 2015 - Pediatric Brain Tumor Foundation
AmoyDx, Supplier of MoBiTec, Germany, Introduces System for Extraction of Circulating DNA from NSCLC (Non-Small Cell Lung Cancer) Patients
Circulating cell-free DNA is an important emerging biomarker in cancer diagnostics as well as a non-invasive diagnostic solution for a wide range of clinical disorders. The AmoyDx kit is specially designed for effective isolation and purification of DNA from peripheral blood (serum or plasma) and pleural effusion. The purified DNA is suitable for downstream applications such as real-time quantitative PCR (qPCR). - June 26, 2015 - MoBiTec GmbH
Motorcyclists in Colorado, Ohio Rally for Kids with Brain Tumors
From the Rocky Mountains to the Buckeye State, motorcyclists hit the road to raise funds for the Pediatric Brain Tumor Foundation at Ride for Kids events on June 14. More than 300 participants gathered in Golden, Colo., and Independence, Ohio, to honor brain tumor survivors Amie, Ashley, Becca,... - June 17, 2015 - Pediatric Brain Tumor Foundation
Creative Bioarray Releases New Human Hair Dermal Papilla Cells
Creative Bioarray, an international supplier of the world's most comprehensive list of research-use cells, including tumor cells, primary cells, stem cells and transformed cells, is pleased to announce its new Human Hair Dermal Papilla Cells ( Cat.No. CSC-C1490) to its primary cells catalog being... - June 11, 2015 - Creative Bioarray
Georgia, Virginia Motorcyclists Ride for Kids with Brain Tumors
Motorcyclists in Georgia and Virginia contributed $170,290 in donations to the Pediatric Brain Tumor Foundation at Ride for Kids events on June 7. Nearly 1,000 participants gathered to help cure the kids in Cumming, Ga., and Mechanicsville, Va. The events honored brain tumor survivors Addison,... - June 10, 2015 - Pediatric Brain Tumor Foundation
Creative BioMart Introduces Oxidative Stress Assay
Creative BioMart, a global leader in the supply of innovative protein research tools and services announced today that it has launched exclusive Oxidative Stress Assay for use in studying many forms of pathophysiology generally associated with aging. Oxidative stress can reflect a disturbance... - June 07, 2015 - Creative Biomart
Now Available at MoBiTec: Ni-IDA Columns for Fast Purification of His-Tagged Proteins
MoBiTec Ni-IDA Columns containing a superior silica-based IDA resin provide a fast and convenient routine tool for purification of recombinant polyhistidine-tagged proteins by gravity flow. - June 05, 2015 - MoBiTec GmbH
Creative Bioarray Launches Stem Cell Assay Development and Screening Service for Cell Research
Creative Bioarray, a biotechnology company offering a comprehensive range of cell services, has recently announced it’s new cells service- stem cell assay development and screening to better serve the increasing customers in the research community. Creative Bioarray supplies a broad range of... - May 30, 2015 - Creative Bioarray
Creative Diagnostics’ Antibodies Are Now on CiteAb
Creative Diagnostics cooperates with the world's largest antibody search engine CiteAb to promote hundreds of its antibody products. - May 29, 2015 - Creative Diagnostics
H. Perry Fell, Experienced BioTech Executive, Joins Board of Recursion Pharmaceuticals
H. Perry Fell, past CEO of Seattle Genetics and NanoString, joins the Board of Recursion Pharmaceuticals. Recursion is an emerging biotech company seeking to combine the best elements of computation and functional genetics to rapidly identify novel therapeutic opportunities for genetic diseases. - May 27, 2015 - Recursion Pharmaceuticals
Creative Diagnostics Reinforces Hi-affinity™ Bacterial Display Platform to Better Produce Therapeutic Antibodies
With the emerging of improved bacterial display technology, an in vitro antibody production technology with highest affinity is available at Creative Diagnostics. - May 27, 2015 - Creative Diagnostics
Creative Diagnostics Launches Sensitive Chemiluminescence Immunoassay Kits for Research Use
Creative Diagnostics announces the launch of Chemiluminescence Kits (CLIA Kits) for research use. - May 27, 2015 - Creative Diagnostics
AdvantaPure(R) Welcomes Cuong M. Nguyen as West Coast Sales Manager; Will Handle Account Support, Management and Development
AdvantaPure announces the appointment of Cuong M. Nguyen to its team. Nguyen fills a new position and brings with him many years of experience in sales management, research, application support and business development involving the pharmaceutical manufacturing and biopharma industries. As Western Regional Sales Manager, Nguyen is responsible for the management and growth of accounts in the western U.S. He will also handle accounts for AdvantaPure’s parent company, NewAge Industries. - May 22, 2015 - AdvantaPure
Tennessee Motorcyclists Ride for a Cure
Hundreds of motorcyclists gathered for the seventh Middle Tennessee Ride for Kids event on May 17 to support the Pediatric Brain Tumor Foundation. Riders raised $121,376 to help cure the kids, as of ride time. The event in Murfreesboro, Tenn., honored local brain tumor survivors Brittani, Jessica,... - May 20, 2015 - Pediatric Brain Tumor Foundation
Curemeta LLC to Present at IBC Life Science 2015
Curemeta LLC, a Boston-based oncology biotech, will be at the IBC Life Science Conference in San Francisco. They will be presenting data on their ADCs which target pluripotent cancer stem cells. - May 16, 2015 - Curemeta LLC
ValueCentricIQ Unveils Innovative Mobile App
The app delivers comprehensive insights, industry trends, and benchmarking tools to the Pharmaceutical IndustryVCIQ Industry Benchmark app is now available on iOS, Android, and Desktop devices - May 13, 2015 - ValueCentric
Brightest Minds Convene to Discuss Research Initiatives
Leading childhood brain tumor researchers from the United States and Canada are gathering today for two Pediatric Brain Tumor Foundation-led scientific meetings in San Diego. This year’s Translating Discoveries to Cure the Kids meeting will bring together 20 experts for a think-tank... - May 08, 2015 - Pediatric Brain Tumor Foundation
Motorcyclists Ride for PBTF in California, North Carolina
Motorcyclists at Ride for Kids events in California and North Carolina over the weekend raised $220,868 for the Pediatric Brain Tumor Foundation. More than 1,200 motorcyclists gathered on May 3 for the Los Angeles and N.C. Triangle Ride for Kids events to honor local brain tumor survivors Amanda,... - May 06, 2015 - Pediatric Brain Tumor Foundation
Curemeta LLC to Present at PEGS Boston
Curemeta LLC, a Boston-based biotech focused on developing antibody drug conjugate therapies for metastatic cancers, announced that they will be presenting their data on novel ADC therapies at the essential Protein Engineering Summit (PEGS) taking place at the Seaport World Trade Center in Boston... - May 03, 2015 - Curemeta LLC
Join the Pediatric Brain Tumor Foundation for Brain Tumor Awareness Month
Brain Tumor Awareness Month in May honors Stars like Brieanan Jerome, who was diagnosed when she was 10 months old. Every day in May on social media, the Pediatric Brain Tumor Foundation's Starlight stories will shine a light on someone affected by a childhood brain tumor. In the days leading up... - May 02, 2015 - Pediatric Brain Tumor Foundation
Creative Biomart Launches an Intuitive New Website Design to Enhance User Experience
Creative Biomart, the leading company in the supply of diagnostic antigens and antibodies, pharmaceutical enzymes, diagnostic enzymes, and high-quality recombinant proteins has launched an intuitive new website design as well as coupon promotion. - April 29, 2015 - Creative Biomart
MoBiTec and GORYO Chemical Ink Distribution Agreement to Sell High-End Calcium Indicators and Cancer-Selective Fluorescent Imaging Probes
MoBiTec GmbH, Germany, focused on selling products for life science and fluorescence applications, has entered into a distribution agreement with GORYO, Japan. Together with GORYO, MoBiTec will continue to expand its portfolio of premier brands. - April 29, 2015 - MoBiTec GmbH
Texas, New Mexico Riders Help Kids with Brain Tumors
Motorcyclists who attended the Albuquerque and Houston Ride for Kids events over the weekend raised $204,491 for the Pediatric Brain Tumor Foundation. More than 450 motorcyclists gathered on April 26 to honor local brain tumor survivors Andres, Ceasar, Garrett, Javier, Joshua, Kaitlyn, Malcolm,... - April 29, 2015 - Pediatric Brain Tumor Foundation
Paras Biopharmaceuticals Finland Oy Selected as First Finnish Company to Present at Cavendish Global
Paras Biopharmaceuticals Finland Oy, an upcoming biopharmaceutical manufacturing company for biosimilars and therapeutic peptides, announced today that it has been selected to present at the Cavendish Global Health Impact Forum taking place 10th - 14th May in La Jolla, California, USA. The purpose... - April 28, 2015 - Paras Biopharmaceuticals Finland Oy
PBTF Supports Research Into Personalized Medicine
The Pediatric Brain Tumor Foundation is investing in a network of children’s hospitals that are researching personalized medicine for children with brain tumors. The Pacific Pediatric Neuro-Oncology Consortium, or PNOC, was formed to provide children with brain tumors access to innovative... - April 25, 2015 - Pediatric Brain Tumor Foundation
Princeton Student Invents Hangover Cure Named Thrive+
While studying neuroscience at Princeton University, then Sophomore Brooks Powell discovered a way to prevent hangovers. He invented Thrive+ and it is now sold online and in select retailers. - April 21, 2015 - Thrive+
Karcinolys Announces the Formation of Pancrealys, Its New Pancreatic Cancer Division
Pancreatic cancer selected as first indication for Targeted HSV-1 derived oncolytic virus Myb34.5. - April 17, 2015 - Karcinolys
Glaucoma Visual Fields Improve Following Stem Cell Treatment
MD Stem Cells reports peripheral vision improvement in glaucoma. - April 12, 2015 - MD Stem Cells
AdvantaPure(R) Publishes White Papers on Clean Room Fluid Transfer, Tubing Selection and Container Closures; Topics Address Issues for Pharma and Biopharma Manufacturers
New from tubing and Single-Use System manufacturer AdvantaPure are three white papers focusing on fluid transfer in pharmaceutical and biopharmaceutical applications. The papers focus on incorporating Single-Use practices for clean room fluid transfer, tubing selection, and the importance of container closures. Developed by the company’s application engineers, the reports offer real world examples of critical fluid transfer applications. - April 09, 2015 - AdvantaPure
The State of California Invests in VIRUN® NutraBIOsciences™; VIRUN® Receives Two More Patent Grants in China While Premiering Esolv® Vitamin E Encapsulator
The State of California has invested in VIRUN, Inc., this along with two newly granted patents in China that correlate with the release of VIRUN’s Esolv®. Algatech to premiere their AstaPure® branded Astaxanthin in a new clear, water soluble powder utilizing VIRUN’s Esolv®, clean label claim encapsulator, for beverage and liquid applications. - April 07, 2015 - VIRUN
Navigen Announces Phase II NIH SBIR Award for the Advancement of Ebola Virus Therapy
Navigen, Inc., a Utah-based drug discovery and development company, has received an NIH award for $2.9 million to develop its anti-Ebola virus D-peptide. Navigen's compound targets a region of the Ebola virus that is 100% conserved and thus should be effective against all strains of virus. - March 24, 2015 - Navigen, Inc.
AveXis EU Ltd. Granted SME Status by the European Medicines Agency
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the European Medicines Agency (EMA) has granted AveXis’ wholly owned European subsidiary,... - March 21, 2015 - AveXis Inc.
Recursion Pharmaceuticals Announces Funding Support for Ataxia-Telangiectasia
Recursion today announced a grant from the AT-Children's Project to advance it's innovative drug discovery work towards identifying novel treatments for ataxia-telangiectasia, a brutal childhood genetic disease. - March 20, 2015 - Recursion Pharmaceuticals
Peptineo Announces Appointment of Dr. Panganiban to Peptineo to Serve as Chief Science Officer
Peptineo is pleased to announce that Nito Panganiban, Ph.D., has been named Chief Science Officer at Peptineo. Dr. Panganiban will be responsible for cultivating core research capabilities, establishing product development roadmaps, and for communicating with key scientific and customer communities... - March 20, 2015 - Peptineo
PBTF Salutes Honda for 25th Year of Support
The Pediatric Brain Tumor Foundation is grateful to American Honda for 25 years of support in the fight against childhood brain tumors. When the company’s Honda Riders Club of America became the presenting sponsor of the PBTF’s Ride for Kids program in 1991, the event was able to... - March 20, 2015 - Pediatric Brain Tumor Foundation
AdvantaPure(R) to Highlight Single-Use Fluid Transfer Innovations at Spring Tradeshows; Includes Appearances in the U.S. and Europe
AdvantaPure will showcase its high purity tubing and Single-Use products at a number of trade shows this spring. Scheduled events will take place in California, New York and Germany. The company will feature its molded manifold assemblies, which are designed to reduce leaks and other risks. Also on hand will be its silicone tubing, AdvantaFlex TPE tubing, AdvantaPass Single-Use fluid transfer technology, BioClosure container closures, process hoses, and hose tracking and identification methods. - March 19, 2015 - AdvantaPure
Creative Bioarray Introduces Hek 293 Cells for Specific Research Needs
The US-based biotech company, Creative Bioarray has recently Introduced Hek 293 cells into its cell repository for meeting customers’ specific research needs. - March 16, 2015 - Creative Bioarray
National Brain Tumor Society Statement on Harold Varmus, MD, Director of the National Cancer Institute and Nobel Laureate
Largest brain tumor nonprofit in the U.S. thanks Harold Varmus for his service and leadership. - March 14, 2015 - National Brain Tumor Society
China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech
China's State Intellectual Property Office to grant Braasch Biotech's patent on Therapeutic treatment of human and pet obesity. - March 13, 2015 - Braasch Biotech LLC
ValueCentric Launches Expansion of Channel Data Visualizations with ValueTrak 7.0
Includes anticipated charting and analytic enhancements for pharmaceutical manufacturers. - March 11, 2015 - ValueCentric
PBTF Names Early Career Development Grant Awardees
The Pediatric Brain Tumor Foundation has awarded its first Early Career Development grants to three up-and-coming pediatric brain tumor researchers studying medulloblastoma and ependymoma. These awards support talented pediatric brain tumor researchers who are early in their career. The recipients... - March 05, 2015 - Pediatric Brain Tumor Foundation
AveXis Announces the Formation of Its European Subsidiary, AveXis EU, Ltd.
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced the formation of its EU-based wholly-owned subsidiary, AveXis EU, Ltd. The subsidiary will allow AveXis... - February 27, 2015 - AveXis Inc.
AnaSpec Launches Industry’s First Amino Acid Pre-loaded Hydrazide Resins
AnaSpec is pleased to announce the launch of the first commercially available Amino Acid Pre-loaded Hydrazide Resins. Native Chemical Ligation (NCL) has been one of the most used bioconjugation methodologies for synthesis of macromolecules. NCL requires a peptide thioester and another peptide... - February 25, 2015 - AnaSpec, EGT Group
Newsletter XVIII Released | MoBiTec GmbH, Germany
The latest edition of the MoBiTec Newsletter is now available for customers to view. It comprises products for genomics & imaging, in vitro diagnostics and assays, interaction screening, magnetic beads as tool in proteomics, and Non-UV transilluminator. - February 18, 2015 - MoBiTec GmbH
Viradux Research, Ltd. Has Expanded the Number of International Shipping Destinations Worldwide and Has Enhanced Its Anti-Herpetic Cream and Lipbalm
Viradux Research, Ltd. announced today that it has expanded the number of international shipping destinations worldwide. Additionally, Viradux has just released to market an improved formulation of its leading anti-herpetic cream Viradux-AU. - February 13, 2015 - viradux
AnaSpec Launches Industry’s First Assay for Measuring Matriptase Activity
AnaSpec is pleased to announce the launch of the first commercially available kit for measuring the activity of Matriptase, a protease implicated in carcinogenesis. The SensoLyte® Rh110 Matriptase Assay Kit provides a convenient assay for screening of Matriptase inhibitors and activators or... - February 13, 2015 - AnaSpec, EGT Group
AdvantaPure(R) Invests in Training Its Team Members; Partners with Worcester Polytechnic Institute for Biomanufacturing Training
Employees from AdvantaPure, a manufacturer of high purity tubing and Single-Use components for biopharma manufacturing, recently received customized training at the Biomanufacturing Education and Training Center of Worcester Polytechnic Institute in Worcester, Mass. The training involved classroom and hands-on instruction to teach the employees about the equipment and processes used by their customers in their pharmaceutical and biopharmaceutical manufacturing operations. - February 07, 2015 - AdvantaPure